Post by Rentschler Biopharma

Are you navigating the ever-evolving landscape of biologics development and manufacturing? Discover how adaptability and a focus on quality can set your organization apart. Our experts, Dr. Marvin Kadisch, Dr.-Ing. Marc Hein, Dr. Martin Pannek, Dr. Alina Handl, Björn Koselack, and Dr. Aileen Roth, have come together to author a comprehensive White Paper packed with actionable insights. Explore how we help our clients overcome their development challenges and drive innovation and excellence. This White Paper, based on two detailed case studies, examines both standard and complex molecules, providing a comprehensive look at diverse challenges and solutions. Access this insightful resource to learn how we are addressing today’s challenges while fostering innovation and maintaining the highest standards. We delve into: ▫️ Successful development strategies for both a standard antibody fragment and a complex heterogeneous molecule ▫️ Implementation of continuous bioprocessing techniques, including perfusion-mode manufacturing and scale-up ▫️ Advanced analytical approaches for ensuring product quality, starting with early-stage development and extending through clinical manufacturing ▫️ Quality by Design (QbD) principles in modern biologics manufacturing, with an emphasis on Critical Quality Attribute (CQA) maintenance ▫️ Solutions for upstream and downstream processing, including resin lifetime optimization and analytical method development Download the White Paper “Using client centricity as fuel for innovative biologics development and manufacturing solutions” now: https://lnkd.in/eky99ZF6 #RentschlerBiopharma #CDMO #ReliabilityYouCanTrust #CaseStudy #WhitePaper